ANAVEX LIFE SCIENCES CORP.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
Business Address 630 5TH AVENUE, NEW YORK, NY, 10111
Mailing Address 630 5TH AVENUE, NEW YORK, NY, 10111
Phone 844-689-3939
Fiscal Year End 0930
EIN 980608404
Financial Overview
FY2025
$15.30M
Total Liabilities
$142.49M
Stockholders' Equity
$132.19M
Cash & Equivalents
$-0.52
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 10-K Annual financial report | November 25, 2025 | View on SEC |
| 8-K Current report of material events | November 14, 2025 | View on SEC |
| 4 Insider stock transaction report | October 3, 2025 | View on SEC |
| 4 Insider stock transaction report | October 3, 2025 | View on SEC |
| 4 Insider stock transaction report | September 12, 2025 | View on SEC |
Annual Reports
10-K November 25, 2025
- Recognized by the SEC as a "well-known seasoned issuer" and "large accelerated filer" with strong internal controls and timely reporting.
- Market value of shares held by regular investors was approximately $708 million as of March 31, 2025, with 89.3 million common shares outstanding by November 24, 2025.
Related Companies
Companies in the same industry (SIC: 2836)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
CRISPR Therapeutics AG
CRSP Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.